Filtered By:
Condition: Hemorrhagic Stroke
Drug: Activase
Education: Training
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
Selection for delayed intravenous alteplase treatment based on a prognostic score
ConclusionSelection of patients between 4·5 and 6 h based on simple clinical measures failed to deliver a population in whom the alteplase effect would be safe and effective.
Source: International Journal of Stroke - January 7, 2013 Category: Neurology Authors: Rachael L Fulton, Kennedy R Lees, Erich Bluhmki, Gabriele Biegert, Gregory W Albers, Stephen M Davis, Geoffrey A Donnan, James C Grotta, Werner Hacke, Markku Kaste, Rüdiger von Kummer, Ashfaq Shuaib, Danilo Toni, , A. Alexandrov, P.W. Bath, L. Claesson, Tags: Research Source Type: research
